AR024671A1 - Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos - Google Patents
Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentosInfo
- Publication number
- AR024671A1 AR024671A1 ARP000103465A ARP000103465A AR024671A1 AR 024671 A1 AR024671 A1 AR 024671A1 AR P000103465 A ARP000103465 A AR P000103465A AR P000103465 A ARP000103465 A AR P000103465A AR 024671 A1 AR024671 A1 AR 024671A1
- Authority
- AR
- Argentina
- Prior art keywords
- ylcarbonyl
- piperazinyl
- formula
- hal
- benzofuran
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical class CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- -1 1-piperazinyl Chemical group 0.000 abstract 9
- 150000001875 compounds Chemical class 0.000 abstract 7
- 150000001907 coumarones Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Derivados de benzofurano de formula (1) en donde R representa 1-piperazinilo, 4-R1piperazinilo o L, R representa 2-R2-5-R3-pirrol-1-ilcarbonilo, 4-R4-piperazin-1-ilcarbonilo, N, N-di(terbutiloxicarbonil)aminocarbonilo, -CH=C(R5R6), benzofuran-2-il-C. ..C-, -C(Hal)3,-CO-C(Hal)3,1,4-dihidrobenzo[d][1,2]oxazin-3-ilcarbonilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilcarbonilo, L representa Cl, Br, I o un grupo OH libre o funcionalmente modificado en un grupo reactivo, R1, R4representan cada cualindependien temente, H, bencilo u otro grupo protector de amino, R2, R3 representan, cada cual independientemente, H, o alquilo C1-6R5, R6 representan cada cual independientemente, alquilo C1-6, Hal representa F, Cl, Br o I, y las sales de estoscompuestos. Unpr ocedimiento para preparar los derivados del benzofurano de formula (1) en el cual a) para preparar compuestos de formula (1) en la cual R representa Cl, Br,I, 1-piperazinilo o 4-R1-piperazinilo, y R representa 2-R2-5-R3-pirrol-1-ilcarbonilo, 4-R4-pip erazin-1-ilcarbonilo, 1,4-dihidrobenzo [d][1,2]-oxazin-3-ilcarbonilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilcarbonilo, se hace reaccionar un compuesto de formula (2) en donde R representa Cl, Br, I, 1-piperazinilo o4-R1-piperazinilo y Q representa Cl, Br , I o un grupo OH libre o funcionalmente modificado en un grupo reactivo, y R1 tiene el significado indicado en lareivindicacion 1, con un compuesto de formula R-H en donde R representa 2-R2-5-R3-pirrol-1-ilo, 4-R4-piperazin-1-ilo, 1,4-dihidrobenzo [d][1,2]- oxazin-3-ilo o 3,4-dihidrobenzo-1H-ftalazin-2-ilo, y R2, R3 y R4 tienen los significados indicados en la reivindicacion 1, o b) para preparar compuestos de formula (1),en la cual R representa Cl, Br, I,1-piperazinilo o 4-R1-piperazinilo, y R representa -CH=C(R5R6), benzofuran-2-il-C...C, -C(Hal)3 o -CO-C(Hal)3, y R1, R5 yR6 tienen los significados indicados en la reivindicacion 1, i) se hace reaccionar un compuesto de la formula (3) en donde Rrepresenta Cl, Br, I, 1-piperazinilo o 4- R1-piperazinilo con un compuesto de formula: Q-CH2-CO-R en donde R representa -CH=C(R5R6), benzofuran-2-il-C...C-, -C(Hal)3 o -CO-C(Hal)3, y
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19932314A DE19932314A1 (de) | 1999-07-10 | 1999-07-10 | Benzofuranderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR024671A1 true AR024671A1 (es) | 2002-10-23 |
Family
ID=7914351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000103465A AR024671A1 (es) | 1999-07-10 | 2000-07-07 | Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6531503B1 (es) |
| EP (1) | EP1194426B1 (es) |
| JP (1) | JP4908706B2 (es) |
| KR (1) | KR100709378B1 (es) |
| CN (1) | CN1178934C (es) |
| AR (1) | AR024671A1 (es) |
| AT (1) | ATE273973T1 (es) |
| AU (1) | AU767413B2 (es) |
| BR (1) | BRPI0012329B8 (es) |
| CA (1) | CA2378603C (es) |
| CZ (1) | CZ301441B6 (es) |
| DE (2) | DE19932314A1 (es) |
| DK (1) | DK1194426T3 (es) |
| ES (1) | ES2226884T3 (es) |
| HK (1) | HK1047275B (es) |
| HU (1) | HU229135B1 (es) |
| IL (2) | IL147494A0 (es) |
| MX (1) | MXPA02000316A (es) |
| MY (1) | MY122667A (es) |
| NO (1) | NO328209B1 (es) |
| PL (1) | PL196477B1 (es) |
| PT (1) | PT1194426E (es) |
| RU (1) | RU2278862C2 (es) |
| SI (1) | SI1194426T1 (es) |
| SK (1) | SK287360B6 (es) |
| TR (1) | TR200200017T2 (es) |
| UA (1) | UA73310C2 (es) |
| WO (1) | WO2001004112A2 (es) |
| ZA (1) | ZA200201085B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006060597A1 (de) * | 2006-12-21 | 2008-06-26 | Merck Patent Gmbh | Verfahren zur Herstellung von Benzofuran-2-carboxamiden |
| EP2110374A1 (en) * | 2008-04-18 | 2009-10-21 | Merck Sante | Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators |
| TWI477497B (zh) | 2009-03-10 | 2015-03-21 | Takeda Pharmaceutical | 苯并呋喃衍生物 |
| WO2011140161A1 (en) | 2010-05-06 | 2011-11-10 | Bristol-Myers Squibb Company | Benzofuranyl analogues as gpr119 modulators |
| EP2566860B1 (en) | 2010-05-06 | 2014-09-10 | Bristol-Myers Squibb Company | Bicyclic heteroaryl compounds as gpr119 modulators |
| CN102964323B (zh) * | 2012-11-13 | 2015-03-25 | 苏州永健生物医药有限公司 | 一种5-（哌嗪-1-基）苯并呋喃-2-甲酰胺的合成方法 |
| PL3009424T3 (pl) * | 2013-06-10 | 2018-03-30 | Astellas Pharma Inc. | Bicykliczny zawierający azot aromatyczny heterocykliczny związek amidowy |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2724915A (en) * | 1955-11-29 | Snow remover | ||
| DE2757532A1 (de) * | 1977-12-23 | 1979-07-05 | Hoechst Ag | N,n'-disubstituiertes cyclisches diamin und verfahren zu dessen herstellung |
| WO1994029290A1 (en) * | 1993-06-14 | 1994-12-22 | Pfizer Inc. | Secondary amines as antidiabetic and antiobesity agents |
| DE4333254A1 (de) | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
| DE19514567A1 (de) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Benzofurane |
-
1999
- 1999-07-10 DE DE19932314A patent/DE19932314A1/de not_active Withdrawn
-
2000
- 2000-06-29 HU HU0201903A patent/HU229135B1/hu not_active IP Right Cessation
- 2000-06-29 EP EP00949229A patent/EP1194426B1/de not_active Expired - Lifetime
- 2000-06-29 JP JP2001509722A patent/JP4908706B2/ja not_active Expired - Fee Related
- 2000-06-29 CA CA2378603A patent/CA2378603C/en not_active Expired - Fee Related
- 2000-06-29 DK DK00949229T patent/DK1194426T3/da active
- 2000-06-29 UA UA2002021055A patent/UA73310C2/uk unknown
- 2000-06-29 PT PT00949229T patent/PT1194426E/pt unknown
- 2000-06-29 MX MXPA02000316A patent/MXPA02000316A/es active IP Right Grant
- 2000-06-29 RU RU2002102234/04A patent/RU2278862C2/ru not_active IP Right Cessation
- 2000-06-29 SI SI200030518T patent/SI1194426T1/xx unknown
- 2000-06-29 CZ CZ20020011A patent/CZ301441B6/cs not_active IP Right Cessation
- 2000-06-29 AU AU62665/00A patent/AU767413B2/en not_active Ceased
- 2000-06-29 IL IL14749400A patent/IL147494A0/xx active IP Right Grant
- 2000-06-29 BR BRPI0012329A patent/BRPI0012329B8/pt not_active IP Right Cessation
- 2000-06-29 KR KR1020017015565A patent/KR100709378B1/ko not_active IP Right Cessation
- 2000-06-29 US US10/030,471 patent/US6531503B1/en not_active Expired - Lifetime
- 2000-06-29 AT AT00949229T patent/ATE273973T1/de active
- 2000-06-29 SK SK6-2002A patent/SK287360B6/sk not_active IP Right Cessation
- 2000-06-29 CN CNB008093083A patent/CN1178934C/zh not_active Expired - Fee Related
- 2000-06-29 WO PCT/EP2000/006089 patent/WO2001004112A2/de active IP Right Grant
- 2000-06-29 DE DE50007501T patent/DE50007501D1/de not_active Expired - Lifetime
- 2000-06-29 PL PL353157A patent/PL196477B1/pl not_active IP Right Cessation
- 2000-06-29 TR TR2002/00017T patent/TR200200017T2/xx unknown
- 2000-06-29 ES ES00949229T patent/ES2226884T3/es not_active Expired - Lifetime
- 2000-07-06 MY MYPI20003075A patent/MY122667A/en unknown
- 2000-07-07 AR ARP000103465A patent/AR024671A1/es active IP Right Grant
-
2002
- 2002-01-06 IL IL147494A patent/IL147494A/en not_active IP Right Cessation
- 2002-01-09 NO NO20020095A patent/NO328209B1/no not_active IP Right Cessation
- 2002-02-07 ZA ZA200201085A patent/ZA200201085B/en unknown
- 2002-11-29 HK HK02108676.2A patent/HK1047275B/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG66094B1 (bg) | Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства | |
| DE69010139T2 (de) | Haarkräftigungsmittel. | |
| MY114679A (en) | Aroyl-piperidine derivatives | |
| DE69415445T2 (de) | Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen | |
| TR200402656T4 (tr) | Antikanser ajanları olarak faydalı tiyofen türevleri | |
| CA2011346A1 (en) | 2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same | |
| BR0108679A (pt) | Novos compostos | |
| UY27368A1 (es) | Nuevos compuestos | |
| CA2054619A1 (en) | Aminocoumaran derivatives, their production and use | |
| WO1998035951A3 (en) | New aminopiperazine derivatives | |
| FR2442845A1 (fr) | Derives amines spiranniques, leur preparation et leur utilisation comme medicaments | |
| ES8304096A1 (es) | "procedimiento para la preparacion de nuevas piriimidinonas". | |
| ES2124545T3 (es) | Azolidindionas como agentes antihiperglucemicos. | |
| EP0353955A3 (en) | Novel compounds | |
| DE60011462D1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
| GB9408185D0 (en) | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| AR024671A1 (es) | Derivados del benzofurano, un procedimiento para su preparacion, y el empleo de los mismos como productos intermedios para la sintesis de medicamentos | |
| BR0309558A (pt) | Derivados de quinazolina e medicamentos | |
| BR9814055A (pt) | Composto, composição farmacêutica, processo para o tratamento de uma doença alérgica, uso do composto, e, processos para preparar e para produzir um composto | |
| ES2090024T3 (es) | Compuestos de cefemo y procedimientos para su preparacion. | |
| CA2436438A1 (en) | 4-aminobenzopyran derivatives | |
| KR940003953A (ko) | 1. 4-벤조디옥산 유도체 | |
| BG106847A (en) | Substituted piperazine derivatives as mtp inhibitors | |
| SE7513391L (sv) | Sett att framstella salter av piperidyl-indolderivat | |
| ES2131549T3 (es) | Derivados macrolidas de 16 eslabones y su procedimiento de preparacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |